2017
DOI: 10.1177/0271678x17712183
|View full text |Cite|
|
Sign up to set email alerts
|

Multimodal partial volume correction: Application to [11C]PIB PET/MRI myelin imaging in multiple sclerosis

Abstract: The [C]PIB PET tracer, originally developed for amyloid imaging, has been recently repurposed to quantify demyelination and remyelination in multiple sclerosis (MS). Myelin PET imaging, however, is limited by its low resolution that deteriorates the quantification accuracy of white matter (WM) lesions. Here, we introduce a novel partial volume correction (PVC) method called Multiresolution-Multimodal Resolution-Recovery (MM-RR), which uses the wavelet transform and a synergistic statistical model to exploit MR… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
14
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
1
1

Relationship

3
4

Authors

Journals

citations
Cited by 22 publications
(18 citation statements)
references
References 43 publications
2
14
0
Order By: Relevance
“…This is consistent with our hypothesis motivated by the existence of a large variability between mRNA expression and protein synthesis due to post-transcriptional regulation mechanisms (Liu et al, 2016). Our findings are consistent with previous works that have linked the spatial architecture of the brain transcriptome to brain structure (Grecchi et al, 2017;Veronese et al, 2015), function (Hawrylycz et al, 2015;Richiardi et al, 2015) and in vivo measures of brain proteins (Gryglewski et al, 2018;Rizzo et al, 2014;Veronese et al, 2016a). Here we could show that post mortem brain mRNA expression data may potentially be used to map also variations in MRI-based functional response to drug stimulation.…”
Section: Microarray Mrna Expression Datasupporting
confidence: 94%
“…This is consistent with our hypothesis motivated by the existence of a large variability between mRNA expression and protein synthesis due to post-transcriptional regulation mechanisms (Liu et al, 2016). Our findings are consistent with previous works that have linked the spatial architecture of the brain transcriptome to brain structure (Grecchi et al, 2017;Veronese et al, 2015), function (Hawrylycz et al, 2015;Richiardi et al, 2015) and in vivo measures of brain proteins (Gryglewski et al, 2018;Rizzo et al, 2014;Veronese et al, 2016a). Here we could show that post mortem brain mRNA expression data may potentially be used to map also variations in MRI-based functional response to drug stimulation.…”
Section: Microarray Mrna Expression Datasupporting
confidence: 94%
“…(Liu et al, 2016). Our findings are consistent with previous works that have linked the spatial architecture of the brain transcriptome to brain structure (Grecchi et al, 2017;Veronese et al, 2015), function (Hawrylycz et al, 2015;Richiardi et al, 2015) and in vivo measures of brain proteins (Gryglewski et al, 2018;Rizzo et al, 2016;Veronese et al, 2016). Here we could show that post mortem brain mRNA expression data may potentially be used to map also variations in MRI functional response to drug stimulation.…”
Section: Microarray Mrna Expression Datasupporting
confidence: 92%
“…Radioligands developed to measure amyloid-β pathology in grey matter for Alzheimer's disease, such as [ 11 [8][9][10] also showed affinity for myelin protein. This is due to the fact that these stilbene and benzothiazole derivatives have a very flat structure, interacting with the secondary structure of myelin basic protein similarly to the way they interact with amyloid [11,12]. In fact, in healthy white matter, myelin basic protein has a particular two-dimensional secondary structure as it acts as a hinge between lipid bilayers.…”
Section: Introductionmentioning
confidence: 99%